ALK-Abelló A/S (OTCMKTS:AKBLF) Shares Down 2.6% – Time to Sell?

ALK-Abelló A/S (OTCMKTS:AKBLFGet Free Report)’s share price fell 2.6% during trading on Tuesday . The stock traded as low as $31.35 and last traded at $31.35. 105 shares traded hands during trading, a decline of 17% from the average session volume of 126 shares. The stock had previously closed at $32.1750.

ALK-Abelló A/S Price Performance

The business’s 50 day moving average is $34.39 and its 200-day moving average is $33.77.

ALK-Abelló A/S Company Profile

(Get Free Report)

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.

Read More

Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.